Atlas Trials

Tris Pharma, Inc.

22 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Tris Pharma, Inc.

RecordFirmDate
A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty (NCT06545097)Tris Pharma, Inc.2024-09-03
A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy (NCT06423703)Tris Pharma, Inc.2024-07-18
A Study to Assess the Abuse Potential of Intranasal Cebranopadol (NCT06453265)Tris Pharma, Inc.2024-06-28
Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain. (NCT05491785)Tris Pharma, Inc.2022-07-29
Assessment of Abuse Potential of Cebranopadol in Humans (NCT05256108)Tris Pharma, Inc.2022-03-28
Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD) (NCT04027361)Tris Pharma, Inc.2019-10-01
Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD (NCT03834766)Tris Pharma, Inc.2019-02-06
Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years (NCT03610464)Tris Pharma, Inc.2018-05-07

Track Tris Pharma, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.